Headline
The latest stories from AHA Today.
Over the next several months, the National Institute of Allergy and Infectious Diseases expects to enroll up to 1,500 adult COVID-19 hospital patients who require supplemental oxygen in a global clinical trial that aims to determine whether baricitinib or dexamethasone is more effective at…
The Centers for Medicare & Medicaid Services has assigned Medicare Severity-Diagnosis-Related Groups to six new ICD-10 diagnosis codes for reporting conditions related to COVID-19 on medical claims effective Jan. 1.
The Department of Health and Human Services seeks comments for 30 days from health care providers and other stakeholders on the need to make permanent any regulatory flexibilities the agency has implemented in response to the COVID-19 public health emergency.
As urged by the AHA, the Centers for Medicare & Medicaid Services gave hospitals facing a surge in COVID-19 patients expanded flexibility to care for Medicare patients outside their walls.
The Centers for Medicare & Medicaid Services issued a final rule revising the requirements for organ procurement organizations that participate in the Medicare and Medicaid programs, as required by an executive order last year.
A new AHA TrendWatch report examines teaching hospitals’ impact on a transforming health care landscape.
The Food and Drug Administration approved using the antiviral treatment Xofluza (baloxavir marboxil) to prevent flu in patients age 12 or older who have been exposed to someone with flu.
The Centers for Disease Control and Prevention updated its recommendations for COVID-19 testing before and after international air travel.
The Food and Drug Administration has posted a webpage with answers to frequently asked questions about face masks, surgical masks and respirators for COVID-19.
The departments of Health and Human Services and Defense announced an $11.6 million contract to domestically produce more nasal swabs for the Cue Health molecular testing system, which detects the COVID-19 virus in about 20 minutes at the point of care.